Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multizenterstudie Der European Assessment Group for Lysis in the Eye (EAGLE) Zur Behandlung Des Zentralarterienverschlusses (ZAV): Lysetherapie Versus Konservative Therapie

NCT00637468 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00637468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00637468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multizenterstudie Der European Assessment Group for Lysis in the Eye (EAGLE) Zur Behandlung Des Zentralarterienverschlusses (ZAV): Lysetherapie Versus Konservative Therapie
Lead sponsor
University Hospital Freiburg
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2002
Completion date
Not reported
Enrollment
84 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

fibrinolysis, hemodilution, retinal artery occlusion, stroke, visual acuity